Neurology

An Innovative Cutaneous Gene Therapy Platform For Metabolic Disorders

SUMMARY The field of metabolic disease treatment has long been challenged by the need for precise, long-term regulation of critical hormones and proteins that manage glucose homeostasis and energy balance. Current therapeutic strategies for conditions such as obesity and diabetes struggle to provide a sustained and adjustable intervention, leaving patients… Read More

COMT inhibitors for impulsive behaviors

SUMMARY Drug repurposing to use catechol-O-methyl-transferase inhibitors for treating impulse control disorders, obsessive-compulsive disorders, and substance addictions The Unmet Need: New options for treating impulsive behavior disorders Impulse control disorders, Obsessive-Compulsive Disorder (OCD), and substance addictions are conditions that significantly impair the… Read More

A New Genetic Medicine Strategy For Treating Neurological Disorders

SUMMARY Synaptic transmission and plasticity are fundamental to neuronal functions, and alterations of synaptic protein expression are direct causes of autism, intellectual disability (ID), and epilepsy. De novo loss-of-function (LoF) mutations in SYNGAP1, encoding the synaptic Ras GTPase-activating protein, are among the most prevalent causes of ID and autism spectrum… Read More